Terms: = Chronic Myelogenous Leukemia AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Prognosis
71 results:
1. Clinical Features of Clonal Cytogenetic Abnormalities in Philadelphia-negative Cells Developed During Tyrosine Kinase Inhibitor Treatment.
Oiwa K; Lee S; Fujita K; Ueda T; Yamauchi T
Intern Med; 2024 Mar; 63(5):729-732. PubMed ID: 37468240
[TBL] [Abstract] [Full Text] [Related]
2. Philadelphia chromosome- positive myelodysplastic syndrome with single lineage dysplasia.
Kumar A; Tilak V; Arora D; Marisha ; Rahul ; Gautam D; Ali A
Cancer Genet; 2023 Aug; 276-277():12-16. PubMed ID: 37267684
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic and therapeutic potential of HO-1 in leukemia and mds.
Sadeghi M; Fathi M; Gholizadeh Navashenaq J; Mohammadi H; Yousefi M; Hojjat-Farsangi M; Namdar A; Movasaghpour Akbari AA; Jadidi-Niaragh F
Cell Commun Signal; 2023 Mar; 21(1):57. PubMed ID: 36915102
[TBL] [Abstract] [Full Text] [Related]
4. Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
Connor MP; Loren AW; Hexner EO; Martin ME; Gill SI; Luger SM; Mangan JK; Perl AE; McCurdy SR; Pratz KW; Timlin C; Freyer CW; Carulli A; Catania C; Smith J; Hollander L; Zebrowski AM; Stadtmauer EA; Porter DL; Frey NV
Transplant Cell Ther; 2023 Feb; 29(2):113-118. PubMed ID: 36336258
[TBL] [Abstract] [Full Text] [Related]
5. [Radiation-induced hematopoietic disorders].
Ando K; Miyazaki Y
Rinsho Ketsueki; 2022; 63(9):981-990. PubMed ID: 36198562
[TBL] [Abstract] [Full Text] [Related]
6. Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes.
Yan X; Wang L; Jiang L; Luo Y; Lin P; Yang W; Ren Y; Ma L; Zhou X; Mei C; Ye L; Xu G; Xu W; Yang H; Lu C; Jin J; Tong H
Cancer Med; 2021 Mar; 10(5):1759-1771. PubMed ID: 33609081
[TBL] [Abstract] [Full Text] [Related]
7. Update on CML-Like Disorders.
Cross NCP
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20 Suppl 1():S101-S102. PubMed ID: 32862848
[TBL] [Abstract] [Full Text] [Related]
8. [Optimization of ATG dose in haploid hematopoietic stem cell transplantation for hematologic malignancies].
Zhou X; Lu X; Tang L; Yan H; Chen WL; Shi W; Zhong ZD; You Y; Xia LH; Hu Y; Wang HF
Zhonghua Xue Ye Xue Za Zhi; 2020 Jul; 41(7):557-563. PubMed ID: 32810962
[No Abstract] [Full Text] [Related]
9. Genetic basis of myelodysplastic syndromes.
Ogawa S
Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(3):107-121. PubMed ID: 32161209
[TBL] [Abstract] [Full Text] [Related]
10. Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.
Sadigh S; Hasserjian RP; Hobbs G
Curr Opin Hematol; 2020 Mar; 27(2):122-127. PubMed ID: 31904665
[TBL] [Abstract] [Full Text] [Related]
11. Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes.
Kawabata H; Usuki K; Shindo-Ueda M; Kanda J; Tohyama K; Matsuda A; Araseki K; Hata T; Suzuki T; Kayano H; Shimbo K; Chiba S; Ishikawa T; Arima N; Nohgawa M; Miyazaki Y; Kurokawa M; Arai S; Mitani K; Takaori-Kondo A;
Int J Hematol; 2019 Nov; 110(5):533-542. PubMed ID: 31359362
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical analysis of myeloid neoplasms with t (3;21) (q26;q22)].
Li Y; Liu Q; Wang Z; Qin YZ; Dang H; Shi Y; He Q; Jiang Q; Jiang H; Lai YY
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):195-199. PubMed ID: 30929385
[No Abstract] [Full Text] [Related]
13. Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasia.
Mashima K; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Umino K; Minakata D; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Ishihara Y; Ashizawa M; Yamamoto C; Fujiwara SI; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
Ann Hematol; 2019 May; 98(5):1127-1133. PubMed ID: 30474718
[TBL] [Abstract] [Full Text] [Related]
14. chronic myeloid leukemia with complex karyotypes: prognosis and therapeutic approaches.
Asnafi AA; Deris Zayeri Z; Shahrabi S; Zibara K; Vosughi T
J Cell Physiol; 2019 May; 234(5):5798-5806. PubMed ID: 30430567
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis.
Arbab Jafari P; Ayatollahi H; Sadeghi R; Sheikhi M; Asghari A
Hematology; 2018 Dec; 23(10):778-784. PubMed ID: 29757120
[TBL] [Abstract] [Full Text] [Related]
16. Secondary pulmonary alveolar proteinosis: a single-center retrospective study (a case series and literature review).
Zhang D; Tian X; Feng R; Guo X; Wang P; Situ Y; Xiao Y; Xu KF
BMC Pulm Med; 2018 Jan; 18(1):15. PubMed ID: 29368649
[TBL] [Abstract] [Full Text] [Related]
17. Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for chronic Myeloid leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options.
Lang F; Wunderle L; Pfeifer H; Schnittger S; Bug G; Ottmann OG
Am J Case Rep; 2017 Oct; 18():1099-1109. PubMed ID: 29033451
[TBL] [Abstract] [Full Text] [Related]
18. Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.
Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Zhang W; Yang L; Yan Y; Lin J; Qian J
J Cell Mol Med; 2017 Aug; 21(8):1468-1481. PubMed ID: 28452111
[TBL] [Abstract] [Full Text] [Related]
19. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid leukemia.
Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
[TBL] [Abstract] [Full Text] [Related]
20. FOXP1 Expression in Normal and Neoplastic Erythroid and Myeloid Cells.
Lovrić E; Pavlov KH; Korać P; Dominis M
Coll Antropol; 2015 Sep; 39(3):755-9. PubMed ID: 26898077
[TBL] [Abstract] [Full Text] [Related]
[Next]
